Molecular Templates, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Common Share (Tables)

Net Loss Per Common Share (Tables)

9 Months Ended

Sep. 30, 2018

Reconciliation of Numerator and Denominator

The following is the calculation of basic and diluted net loss per share (in thousands, except share and per share data):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2018		2017		2018		2017
Numerator:
Net loss attributable to common shareholders	$	5,244	$	11,105	$	23,653	$	17,183
Denominator:
Weighted average common shares outstanding - basic and diluted		27,680,307		17,925,585		27,246,667		6,241,947
Net loss per share attributable to common shareholders:
Basic and diluted	$	0.19	$	0.62	$	0.87	$	2.75

Warrants and Options Excluded from Computation of Diluted Net Loss Per Share

The following outstanding warrants and options were excluded from the computation of diluted net loss per share for the periods presented because including them would have had an antidilutive effect (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2018		2017		2018		2017
Shares issuable upon exercise of warrants		3,522		3,274		3,522		3,274
Shares issuable upon exercise of stock options		4,201		1,870		4,201		1,870